SOPHiA GENETICS WORKSHOP: Athens

Dear Collaborators,

We have the pleasure and the privilege to invite you to join our one-day workshop "Advanced NGS diagnostics for hematological disorders", which will take place in Athens, on Monday, October 22, 2018, at the Golden Age Hotel

Our experts and partners will take you through the challenges of hematological disorder diagnostics and showcase our products and services aimed to support clinicians in the development of personalized treatment options.

A full event program will be made available shortly. We are at your disposal for any further information concerning this event.

We look forward to having you here. For organizational reasons, kindly reserve your place on the link below.

Hope to see you there,

Your SOPHiA GENETICS team

14:30: Registration

15:00: Welcome and introduction

- Thanasis Athanasopoulos, Ph.D. - Director, Molecular Diagnostics & Life Sciences division –

SafeBlood BioAnalytica

15:10: Reaching clinical-grade performance on genomic testing

- Alexandros Kouskoukis, Ph.D. - Sales & Business Development Manager - SOPHiA GENETICS

15:30: Precision medicine in hematologic malignancies: potential, challenges and considerations

- Kostas Stamatopoulos, MD., Ph.D. - Institute of Applied Biosciences at CERTH, the Center for Research and Technology Hellas, Thessaloniki, Greece

15:50: Myeloid Solution on Acute Myeloid Leukemia validation program results

- Maria Teresa Bochicchio, Ph.D. - Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Institute of Hematology "L. e A. Seràgnoli" - Italy

16:20: Coffee break

16:30: NGS diagnostics in myeloid malignancies: why, when and how

- Prof. Panagiotis Panagiotidis, MD., Ph.D. - National and Kapodistrian University of Athens, Department of Pathology Clinic at "LAIKO", Athens, Greece

16:50: NGS diagnostics in Myeloid Malignancies - Our experience

- Pantelis Constantoulakis, Ph.D. - Molecular Genetics Director - GENOTYPOS

17:10: New clinical applications for targeting malignant myeloid and lymphoid disorders

- Pierluigi Iapicca, Ph.D. - Subject Matter Expert - SOPHiA GENETICS

17:30: Closing remarks - Discussion

- Thanasis Athanasopoulos, Ph.D. - Director, Molecular Diagnostics & Life Sciences division –

SafeBlood BioAnalytica

18:30: Reception - presentation of Genotypos NGS laboratory